L’année 2015 à travers le regard du comité de rédaction du Bulletin du cancer-Reference-Cited by-同舟云学术

L’année 2015 à travers le regard du comité de rédaction du Bulletin du cancer

Published:2016-01 Issue:1 Volume:103 Page:3-17
ISSN:0007-4551
Container-title:Bulletin du Cancer
language:fr
Short-container-title:Bulletin du Cancer

Author:

Magné Nicolas,Massard Christophe,Bay Jacques-Olivier,André Thierry,Blay Jean-Yves,Goncalves Anthony,Orbach Daniel,Wislez Marie,Thariat Juliette,Penel Nicolas,Rancoule Chloé,Vignot Stéphane

Publisher

Elsevier BV

Subject

Cancer Research,Radiology Nuclear Medicine and imaging,Oncology,Hematology,General Medicine

Reference78 articles.

1. Ibrutinib versus ofatumumab in previously treated chronic lymphoid leukemia;Byrd;N Engl J Med,2014

2. Three-year follow-up of treatment-naïve and previously treated patients with CLL and SLL receiving single-agent ibrutinib;Byrd;Blood,2015

3. Targeting BTK with ibrutinib in relapsed or refractory mantle-cell lymphoma;Wang;N Engl J Med,2013

4. Idelalisib and rituximab in relapsed chronic lymphocytic leukemia;Furman;N Engl J Med,2014

5. PI3Kδ inhibition by idelalisib in patients with relapsed indolent lymphoma;Gopal;N Engl J Med,2014

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Economic evaluation of sequencing strategies in HER2-positive metastatic breast cancer in Mexico: a contrast between public and private payer perspectives;Breast Cancer Research and Treatment;2017-08-24

2. Quels résultats de l’année 2016 vont avoir un impact sur nos pratiques ? Le point de vue du Comité de rédaction du Bulletin du Cancer;Bulletin du Cancer;2017-01